Erratum: Author correction to 'Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects' [Acta Pharmaceutica Sinica B 13 (2023) 2138-2151].
Acta Pharm Sin B
; 14(3): 1477, 2024 Mar.
Article
in En
| MEDLINE
| ID: mdl-38486984
ABSTRACT
[This corrects the article DOI 10.1016/j.apsb.2022.12.009.].
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Acta Pharm Sin B
Year:
2024
Document type:
Article
Affiliation country: